secwatch.observer — SEC 8-K summary
======================================

Issuer:     ImmunityBio, Inc. (IBRX)
CIK:        0001326110
Form:       8-K
Filed at:   2023-09-01T23:59:59+00:00
Accession:  0001326110-23-000112
Event type: litigation
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ImmunityBio subsidiary to enforce settlement as Sorrento fails to pay judgments
-------------------------------------------------------------------------------

- Sorrento failed to pay judgments held by NantCell and NANTibody by August 31, 2023 deadline.
- NantCell and NANTibody to deliver certification of non-payment by September 6, triggering settlement terms.
- Upon certification, mutual release of claims, release of judgments, and Sorrento relinquishes NANTibody interests.
- Sorrento forfeits rights to payments from antibody license including royalties from PD-L1 t-haNK NK cell therapy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326110/000132611023000112/0001326110-23-000112-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326110/000132611023000112/ibrx-20230831.htm
  HTML page:      https://secwatch.observer/filing/0001326110-23-000112

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer